These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8247182)

  • 1. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients.
    Harnett JD; Murphy B; Collingwood P; Purchase L; Kent G; Parfrey PS
    Nephron; 1993; 65(2):212-4. PubMed ID: 8247182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
    Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
    Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients.
    Grebe SJ; Malzahn U; Donhauser J; Liu D; Wanner C; Krane V; Hammer F
    Cardiovasc Ultrasound; 2020 Sep; 18(1):39. PubMed ID: 32938484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
    Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Stancanelli B; Cataliotti A; Malatino LS
    Kidney Int; 2004 Apr; 65(4):1492-8. PubMed ID: 15086493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients.
    Ayerden Ebinç F; Ebinç H; Derici U; Aral A; Aybay C; Taçoy G; Koç E; Mutluay R; Altok Reis K; Erten Y; Arinsoy T; Sindel S
    J Nephrol; 2009; 22(2):216-23. PubMed ID: 19384839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography.
    Chang ST; Chen CC; Chen CL; Cheng HW; Chung CM; Yang TY
    Blood Purif; 2004; 22(4):351-9. PubMed ID: 15297785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study.
    Peteiro J; Alvarez N; Calviño R; Penas M; Ribera F; Castro Beiras A
    Cardiology; 1994; 85(5):273-83. PubMed ID: 7850816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.
    Yildiz A; Akkaya V; Hatemi AC; Cine N; Tükek T; Görçin B; Demirel S; Türk S; Sever MS
    Nephron; 2000 Feb; 84(2):130-5. PubMed ID: 10657713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
    Chan CT; Floras JS; Miller JA; Richardson RM; Pierratos A
    Kidney Int; 2002 Jun; 61(6):2235-9. PubMed ID: 12028465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin correlates with body mass index and to a lesser extent with left ventricular mass in dialysis patients.
    Poniku A; Bajraktari G; Elezi S; Ibrahimi P; Henein MY
    Cardiol J; 2018; 25(4):501-511. PubMed ID: 28980284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
    Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
    Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.